Indegene opens new office in Pune

Life sciences commercialisation firm Indegene has expanded its presence in India with a new centre launch in Pune.

Indegene hopes to leverage the city’s highly skilled technology, management, and medical talent base, the company is enhancing its ability to help clients accelerate innovation, scale global operations, and deliver improved healthcare outcomes for patients worldwide.

Headquartered in Bengaluru, Indegene combines healthcare expertise with digital tech to help pharma, biotech and medical device companies commercialise their products. Its client base includes 20 biopharma companies, many emerging biotech firms, and medical device companies. Indegene has about 5,000 employees worldwide, with centres across North America, Europe, and Asia.

To be sure, in November 2024, Indegene opened a center in Hyderabad, India. The facility supports the company’s global operations and meet the increasing demands of the pharmaceutical industry.

In an earlier interview with TechCircle, chief technology officer, Tarun Mathur, said, “We are currently addressing a large and growing market opportunity. We believe the headroom for growth is significant over the next 5-10 years and beyond. With emerging therapies in immunology, neurology, and oncology, the number of pharma product launches is expected to increase significantly in the next 3-5 years.”

He added that regulatory pressures in key markets such as the US and EU, rising healthcare costs, and other macro developments are expected to push life sciences companies to adopt more efficient, technology-driven approaches to drug commercialisation.

“We plan to play a pivotal role in this growth by leveraging our technological expertise and helping pharma companies get their commercialisation journey right, with a data-driven, AI-first approach.”